Navigation Links
Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
Date:11/4/2010

applications (BLAs) and BLA supplement (BLS) applications for therapeutic biological drugs regulated by CDER.

As the Agency’s leading drug expert on the International Conference on Harmonization (ICH) Q7 Expert Working Group, Mr. Rivera-Martinez played a key role in the development and implementation of the ICH guidance entitled “Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients.”  For the last two and a half years, he also served as the Agency’s technical drug CGMP expert on the ICH Q11 Expert Working Group tasked with developing an internationally harmonized guidance for the development and manufacture of drug substances.

From 1990 to 2002, Mr. Rivera-Martinez served as Compliance Officer in DMPQ.  Prior to transferring to CDER, he worked for 13 years as an Investigator in the FDA’s San Juan, Puerto Rico District office, where he specialized in the inspection, auditing, and investigation of complex, state-of-the-art active pharmaceutical ingredient and drug production facilities.  From 1988 to 1990, while in San Juan, he participated in a joint Pan American Health Organization (PAHO)/FDA cooperative program. As a Regional Consultant in PAHO’s Essential Drugs Program, he coordinated and presented six drug quality assurance and CGMP training courses in Latin America that resulted in the training of over 400 drug regulatory authority and industry personnel.

“The appointment of Mr. Rivera-Martinez to PAREXEL’s team of strategic compliance and regulatory experts reinforces our commitment to helping clients proactively manage the risk of potential safety issues, as well as product delays and failures on a global scale,” said David L. Chesney, Vice President and Practice Lead, Strategic Compliance Services, PAREXEL Consulting.  “Extremely well-versed in regulations, CGMP compliance and enforcement, as well as ICH guidance, he brings a level of t
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Former Speaker of the House Newt Gingrich Featured Wednesday
2. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
3. Former Cables to Go/Lastar Inc. Employee's Move to Form American Consumer Cables Pays Off
4. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
5. Former Telomolecular CEO Clarifies SEC Settlement
6. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
7. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
8. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
9. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
10. Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America
11. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015  Neurotech Pharmaceuticals, Inc., announced today ... multicenter Phase 2 clinical trial of NT-503 Encapsulated ... recurrent subfoveal choroidal neovascularization secondary to age related ... vascular endothelial growth factor (VEGF) receptor protein continuously ... "This landmark proof-of-concept study will evaluate NT-503 ECT ...
(Date:9/2/2015)... ZIONA, Israel , September 2, 2015 ... BVXV) today announced the intent of the National Institute of ... Institutes of Health (NIH) within the Department of Health and ... to be held in the United States ... use of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... equipment, to creating professional commercial video content, to analysis of athletic performance. Producing ... events that go by too quickly to process with the naked eye. ...
(Date:9/1/2015)...  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... Global Investment Conference sponsored by H.C. Wainwright ... St. Regis Hotel in New York, NY ... Chief Executive Officer, will provide an overview of the ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... , ... ... ... ...
... ... ... ... ...
... , ... for Rare Disease Day, hopes to bring more attention to the need for finding more ... ... hopes to draw more attention to the urgent need of finding more treatments for rare ...
Cached Biology Technology:Merck KGaA and Millipore Announce Transaction - Video Interview with Merck CEO 2Merck KGaA and Millipore Announce Transaction - Video Interview with Merck CEO 3Merck KGaA and Millipore Announce Transaction - Video Interview with Merck CEO 4Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 2Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 3Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 4Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 5Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 6Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 7Raising Awareness of Rare Diseases, Anson Group Announces Sponsorship of Rare Disease Day 2
(Date:8/6/2015)... JOSE, Calif. , Aug. 6, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... TouchPad technologies on Windows 10. Microsoft leveraged Synaptics, ... to the operating system. Through ... drivers are fully certified with Microsoft,s Precision TouchPad ...
(Date:8/4/2015)... Aug. 04, 2015 ... has announced the addition of the ... and Service), Sub-Segment (Computer Forensics, Network Forensics, ... Types, Service, Vertical and Region - Global ... offering. By Component (Hardware, Software, ...
(Date:7/31/2015)... julio de 2015 BGI llevará a cabo la ... 22 al 25 de octubre de 2015, en ... celebra su décimo aniversario este año. Desde su inauguración ... las reuniones anuales más influyentes del mundo en los ... conferencias científicas más dinámicas, entusiastas y amenas. ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... a molecule on the surface of B cells, a finding ... insidious attack on the immune system, University of Pittsburgh researchers ... , "The research supports a new role for B cells ... important implications for future studies and drug development efforts that ...
... "off" switch packaged in a tiny sphere penetrates deeply ... and drastically reducing the size of tumors, researchers at ... report in the Aug. 15 edition of Clinical Cancer ... cover of the journal, demonstrates a potent delivery system ...
... reported this week reveal that at least some primates can ... for guiding their foraging behavior when searching for ripening fruit. ... skills developed in humans and other primates, is reported by ... of St. Andrews in the June 20th issue of Current ...
Cached Biology News:HIV infection requires an accomplice: B cells with special protein direct HIV to T cells 2Fatty spheres loaded with siRNA shrink ovarian cancer tumors in preclinical trial 2Fatty spheres loaded with siRNA shrink ovarian cancer tumors in preclinical trial 3Primates take weather into account when searching for fruits 2
Homogenizing Solution, 18ml Proteinase K - [50ug/l] 75 l...
Lipofectin Reagent is the reagent of choice for some cell lines; cells of endothelial derivation transfect well with Lipofectin Reagent....
Request Info...
... peptide derived from the internal region of ... Specific for the internal region of the ... the target band at ~590 kDa. ... media from primary tracheobranchial epithelial cultures and ...
Biology Products: